Shreepati Pharmaceuticals

Indore, India Founded: 1996 • Age: 30 yrs
Manufactures and exports raw materials for the pharmaceutical industry.

About Shreepati Pharmaceuticals

Shreepati Pharmaceuticals is an Industrial Goods & Manufacturing company based in Indore (India) founded in 1996. It manufactures and exports raw materials for the pharmaceutical industry. It operates on a B2B model. The company has 53 employees. Its Indian entity Shreepati Pharmaceuticals Pvt Ltd reported revenue of β‚Ή27.91 Cr. Its focus areas include Manufacturing, Pharmaceuticals, Raw Materials and Export. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Shreepati Pharmaceuticals, based in Indore, focuses on producing manufactured goods, producing pharmaceutical products, raw materials, and export. Manufactures and exports raw materials for the pharmaceutical industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹27.91 Cr

    FY 2025 · +7% YoY

  • Net Profit
    ₹1.56 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹4.35 Cr

    FY 2025 · 16% margin

  • Employee Count
    53

Board of directors of Shreepati Pharmaceuticals Pvt Ltd (Shreepati Pharmaceuticals)

Shreepati Pharmaceuticals Pvt Ltd is the primary company behind Shreepati Pharmaceuticals. The board of Shreepati Pharmaceuticals Pvt Ltd currently have 4 directors; the longest-serving is Rajesh Muchhal, appointed in 1999. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajesh Muchhal
DIN 00137701
Director16 Jun 199927 yrs 4 moShreepati Pharmaceuticals Pvt Ltd
Ravi Muchhal
DIN 00137912
Director16 Jun 199927 yrs 4 moShreepati Pharmaceuticals Pvt Ltd
Vedant Muchhal
DIN 07134761
Director28 Mar 201610 yrs 7 moShreepati Pharmaceuticals Pvt Ltd
Dhiraj Muchhal
DIN 07134742
Director28 Mar 201610 yrs 7 moShreepati Pharmaceuticals Pvt Ltd

Financials of Shreepati Pharmaceuticals

Figures of Shreepati Pharmaceuticals Pvt Ltd, the primary company behind Shreepati Pharmaceuticals, for FY 2025. Revenue was ₹27.91 Cr (+7% year on year). Net profit was ₹1.56 Cr (6% margin). EBITDA was ₹4.35 Cr (16% margin). Revenue has grown at a compounded annual rate of +9% over three years and +3% over five years.

  • ₹27.91 CrRevenue · FY 2025 · +7% YoY
  • ₹1.56 CrNet profit · 6% margin
  • ₹4.35 CrEBITDA · 16% margin
  • ₹4.6 LakhPaid-up capital
  • 53Employees (provident fund records)
  • +9%Revenue CAGR, 3 years
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Shreepati Pharmaceuticals Pvt Ltd are on its company page.

Premium access

Detailed financial statements for Shreepati Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Shreepati Pharmaceuticals

Shreepati Pharmaceuticals has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Shreepati Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Metals & Minerals

3 companies that operate in the same segment as Shreepati Pharmaceuticals (Metals & Minerals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of pipes, plates & coils, and home textile products
1985Mumbai, Maharashtra, IndiaUSD 544.74 M6,934
Chemical and casting products are manufactured, with shipping operations managed.
1962Chennai, Tamil Nadu, IndiaUSD 576.61 MUSD 1.43 B180
Diversified operations span automotive, agriculture, and financial services.
1945Mumbai, Maharashtra, IndiaUSD 45.15 MUSD 20.78 B78,760
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Shreepati Pharmaceuticals

Shreepati Pharmaceuticals was founded in 1996.

Shreepati Pharmaceuticals is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.

Shreepati Pharmaceuticals has 53 employees.

The primary company behind Shreepati Pharmaceuticals, Shreepati Pharmaceuticals Pvt Ltd, reported revenue of β‚Ή27.91 Cr for FY 2025, up 7% year on year.

Shreepati Pharmaceuticals, based in Indore, focuses on producing manufactured goods, producing pharmaceutical products, raw materials, and export. Manufactures and exports raw materials for the pharmaceutical industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Shreepati Pharmaceuticals's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Shreepati Pharmaceuticals operates through Shreepati Pharmaceuticals Pvt Ltd.

The legal entities of Shreepati Pharmaceuticals currently have 4 directors, including Rajesh Muchhal, Vedant Muchhal, Dhiraj Muchhal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available